News

Filter

Current filters:

OncologyMedImmune

1 to 9 of 15 results

MedImmune to acquire company to strengthen focus on biomarkers in immuno-oncology

MedImmune to acquire company to strengthen focus on biomarkers in immuno-oncology

04-11-2014

MedImmune, a US subsidiary of Anglo-Swedish pharma major AstraZeneca has entered into an agreement to…

AstraZenecaDefiniensMedImmuneMergers & AcquisitionsOncologyPharmaceutical

AstraZeneca's Medimmune to collaborate on new oncology biologics lab with Cancer Research UK

AstraZeneca's Medimmune to collaborate on new oncology biologics lab with Cancer Research UK

25-09-2014

Medimmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca,…

BiotechnologyCancer Research TechnologyCancer Research UKMedImmuneOncologyResearchUK

AstraZeneca's MedImmune announces cancer immunotherapies partnership with Advaxis

AstraZeneca's MedImmune announces cancer immunotherapies partnership with Advaxis

22-07-2014

Anglo-Swedish drug major AstraZeneca says that its global biologics research and development arm MedImmune…

AdvaxisADXS-HPVAstraZenecaBiotechnologyMedImmuneOncologyPapillomavirusResearchSweden

AstraZeneca showcases much awaited oncology pipeline at ASCO 2014

AstraZeneca showcases much awaited oncology pipeline at ASCO 2014

03-06-2014

Anglo-Swedish drug major AstraZeneca provided an update on the rapid development of its oncology pipeline…

AstraZenecaAZD9291MED14736MedImmuneOncologyPharmaceuticalResearchtremelimumab

MedImmune and Incyte to collaborate on immunotherapy

MedImmune and Incyte to collaborate on immunotherapy

14-05-2014

MedImmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca,…

AstraZenecaBahija JallalIncyteL1LicensingMajorMedImmuneOncologyPharmaceuticalTumorTumorsUKUSA

Medimmune announces research deals with University of Cambridge and University of Texas

Medimmune announces research deals with University of Cambridge and University of Texas

18-03-2014

USA-based MedImmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca,…

MedImmuneOncologyPharmaceuticalResearchUKUSA

AstraZeneca in deal with Immunocore to develop novel cancer therapies

AstraZeneca in deal with Immunocore to develop novel cancer therapies

08-01-2014

UK privately-held biotech firm Immunocore has signed an oncology research collaboration and licensing…

AstraZenecaBiotechnologyImmunocoreLicensingMedImmuneOncologyResearch

1 to 9 of 15 results

COMPANY SPOTLIGHT

Menarini

Back to top